Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02625610
Title Avelumab in First-Line Gastric Cancer (JAVELIN Gastric 100)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Avelumab

Capecitabine + Oxaliplatin

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.